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Abstract 
Background: Malaria parasites have evolved a series of intricate mechanisms to survive and propagate within host 
red blood cells. Intra-erythrocytic parasitism requires these organisms to digest haemoglobin and detoxify iron-
bound haem. These tasks are executed by haemoglobin-specific proteases and haem biocrystallization factors that 
are components of a large multi-subunit complex. Since haemoglobin processing machineries are functionally and 
genetically linked to the modes of action and resistance mechanisms of several anti-malarial drugs, an understanding 
of their evolutionary history is important for drug development and drug resistance prevention.
Methods: Maximum likelihood trees of genetic repertoires encoding haemoglobin processing machineries within 
Plasmodium species, and with the representatives of Apicomplexan species with various host tropisms, were created. 
Genetic variants were mapped onto existing three-dimensional structures. Genome-wide single nucleotide polymor-
phism data were used to analyse the selective pressure and the effect of these mutations at the structural level.
Results: Recent expansions in the falcipain and plasmepsin repertoires are unique to human malaria parasites 
especially in the Plasmodium falciparum and P. reichenowi lineage. Expansion of haemoglobin-specific plasmepsins 
occurred after the separation event of Plasmodium species, but the other members of the plasmepsin family were 
evolutionarily conserved with one copy for each sub-group in every Apicomplexan species. Haemoglobin-specific 
falcipains are separated from invasion-related falcipain, and their expansions within one specific locus arose inde-
pendently in both P. falciparum and P. vivax lineages. Gene conversion between P. falciparum falcipain 2A and 2B 
was observed in artemisinin-resistant strains. Comparison between the numbers of non-synonymous and synony-
mous mutations suggests a strong selective pressure at falcipain and plasmepsin genes. The locations of amino acid 
changes from non-synonymous mutations mapped onto protein structures revealed clusters of amino acid residues 
in close proximity or near the active sites of proteases.
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Background
Malaria parasites belong to the Plasmodium genus with four 
established human malaria species, namely, Plasmodium 
falciparum, P. malariae, P. ovale, and P. vivax [1]. Several 
Plasmodium parasites also infect non-human hosts, such 
as rodent (P. berghei and P. chabaudi) and chimpanzee (P. 
reichenowi) [2]. Plasmodium spp. belong to the Apicomplexa 
phylum and contain apicoplast, a plastid-like organelle that 
is an indicator of close evolutionary relationship between 
the ancestors of plants and apicomplexan species [3]. Sev-
eral members of the Apicomplexa phylum are pathogens of 
human and veterinary diseases with the capability to infect 
a broad range of cell types. Malaria parasites are evolution-
arily equipped with intricate machineries to degrade host 
haemoglobin (Hb) during their intra-erythrocytic stages of 
development. With an estimated Hb concentration of 5 mM, 
the red blood cell is an ideal host cell for supply of amino 
acid nutrient [4]. Nevertheless, Hb-rich environment could 
be a potentially hostile milieu for malaria parasites owing to 
the iron-containing haem released from the digested pro-
tein. Plasmodium employs a series of proteases for digest-
ing globin and, lacking haem oxygenase within the acidic 
digestive vacuole, releases free haem molecules that form 
dimers linked together via H-bonds between the carboxyl 
side chains of the protoporphyrin rings [5]. This arrange-
ment allows the formation of a crystal-like pigment (known 
as haemozoin) and keeps haem iron and free haem from 
causing oxidative and membrane damage (Fig.  1) [6]. It is 
worth tracing the evolutionary pathway by which a group of 
single-celled protozoa has achieved this remarkable feat. This 
issue is also of clinical importance in view of the number of 
anti-malarials that act by interfering with this Hb processing 
apparatus [7, 8]. Changes in genes encoding these proteins 
are known to alter anti-malarial sensitivity [9, 10]. Identify-
ing the origin of malaria parasite Hb processing machinery 
and the effect of selective pressure on its evolution might 
help reveal Plasmodium variants specific to anti-malarial 
resistance.
In order for Plasmodium to evolutionarily become a 
parasite of red blood cells, it has to gain two functions, 
namely, Hb degradation and haem detoxification. The cel-
lular machinery required for executing these two tasks 
has been biochemically and functionally characterized 
in P. falciparum to occur within a single protein com-
plex (Fig. 1) [11]. The major component of the complex is 
haem detoxification protein (HDP), which catalyzes haem 
biocrystallization by tethering haem molecules together 
[12]. Three families of proteases, namely, cysteine protease 
(falcipain 2A and falcipain 2B), aspartic protease (plas-
mepsin II, III and IV) and metalloprotease (falcilysin) are 
associated with the complex [11]. These proteases have 
been functionally shown to target Hb [6]. The diversity and 
redundancy in Hb-targeted proteases indicate that the pro-
cess of Hb degradation is vital for malaria survival as the 
evolutionary process has generated an array of proteases 
to accomplish the task. These proteases target different Hb 
parts and act sequentially to degrade globin chains [6].
Genetic alterations of Hb processing genes are linked 
to loss in anti-malarial drug sensitivity. For instance, 
knock-out of falcipain 2A reduces artemisinin sensitivity 
[13]. Interestingly, a mutation in falcipain 2A also arose 
during long-term selection of artemisinin resistance [14]. 
Both artemisinin and chloroquine inhibit HDP complex 
function, but with different modes of action [10, 11]. In 
addition, quinolone anti-malarials also affect Hb degra-
dation and haem detoxification [7]. The selective pressure 
from such drugs is likely to alter the course of parasite 
evolution through changes in genes encoding members 
of the HDP complex, especially in ‘hotspot’ areas of drug 
resistance in Southeast Asia, where there is well-estab-
lished evidence for loss in artemisinin sensitivity [15].
Here, the evolution history of Plasmodium protease 
families known to target Hb, including members of the 
HDP complex, was traced. Variations of P. falciparum 
HDP complex genes obtained from subjects in hotspot 
areas, including those from emerging artemisinin-resist-
ant isolates, were analysed and mapped onto protein 
structures. Genes under selective pressure and mutations 
at key positions are described.
Methods
Phylogenetic analysis
Amino acid sequences of falcipains, plasmepsins, falci-
lysin, and HDP from P. falciparum strain 3D7 were 
retrieved from NCBI Protein database (Additional file 1) 
and SNP data of P. falciparum candidate genes were 
obtained from MalariaGEN [16]. Sequences from P. falci-
parum were used as a BLAST query against non-redun-
dant protein sequence database (nr). BLASTp parameters 
were set as follows: scoring matrix, BLOSUM62; gap pen-
alty, 11; and, gap extension penalty, 1. BLASTp hits that 
fulfilled the following criteria were selected as candidates 
Conclusion: A high degree of polymorphism at the haemoglobin processing genes implicates an imposition of 
selective pressure. The identification in recent years of functional redundancy of haemoglobin-specific proteases 
makes them less appealing as potential drug targets, but their expansions, especially in the human malaria parasite 
lineages, unequivocally point toward their functional significance during the independent and repetitive adaptation 
events in malaria parasite evolutionary history.
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for further analysis: (1) E-value  <10−6; (2) alignment 
score >80; and, (3) BLAST alignment covering the func-
tional domain. Homologue candidates in other Plasmo-
dium spp. (P. reichenowi, P. vivax, P. knowlesi, P. berghei, 
and P. yoelii) and other protozoa (Babesia bovis, Babe-
sia microti, Eimeria tenella, Toxoplasma gondii, Theile-
ria parva, and Theileria annulata) were retrieved from 
NCBI database. The DNA sequences encoding falcipain 
2A and falcipain 2B from P. reichenowi PrCDC were 
obtained by de novo assembly [17]. Sequences of interest 
were aligned using MUSCLE [18, 19]. Neighbour-joining 
(NJ) tree and 1000 bootstrap replicates were constructed 
using ClustalX version 2.0 [20]. The best-fit protein evo-
lutionary model was determined using ProtTest [21]. 
Unrooted maximum likelihood (ML) tree was estimated 
using RAxML software [22, 23] and constructed using 
Dendroscope version 3.2.10 [24].
Nested‑PCR and sequence analysis of falcipain genes
In nested-PCR amplification of falcipain 2A and falcipain 
2B genes, first round PCR was performed in a 25-µl reaction 
containing 1X HF buffer (Thermo Scientific), 1.5 mM MgCl2 
for falcipain 2A or 5 mM MgCl2 for falcipain 2B, 0.5 pmol of 
dNTPs, 10 pmol of each primer (Additional file 2), 25 ng of 
parasite DNA, and 0.2 U Phusion DNA polymerase (Thermo 
Scientific). PCR was performed in an Eppendorf Mastercy-
cler Pro under the following conditions: 98  °C for 30  s; 35 
cycles of 98 °C for 10 s, 55 °C for 30 s, and 72 °C (for falcipain 
Fig. 1 Diagram depicting haemoglobin degradation and haemozoin synthesis in Plasmodium falciparum. Haemoglobin is taken up into the 
parasite via cytostome, passing through parasite membrane and parasitophorous vacuole membrane (PVM). Double-membrane vesicle containing 
red blood cell content as observed in a cross-section delivers Hb into the food vacuole [50]. A series of proteases in the plasmepsin (PM), falcipain 
(FP) and falcilysin (FLN) family digest Hb into either free amino acid or short peptide. Haem from digested Hb is packed into polymerized crystal 
called haemozoin with help from haem detoxification protein (HDP) and histidine-rich protein (HRP). Lipid biomolecules from either food vacuole 
membrane or droplet are suggested to promote haemozoin synthesis probably by seeding and directing crystal growth [51]
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2A) or 68 °C (for falcipain 2B) for 135 s; and, 72 °C for 5 min. 
Second-round PCR was carried out as described above 
except that 1 µl of 10−4 dilution of first-round PCR solution, 
second-round PCR primers (Additional file 2) and the exten-
sion step of 72 °C for 45 s were used. The nested-PCR ampli-
cons were sequenced in both directions in ABI3130XL DNA 
sequencer (Applied Biosystems).
Homology modelling and structural analysis
Structural data of plasmepsin I (accession no 3QS1), 
plasmepsin II (accession no 1XDH), HAP (accession no 
3FNT), falcipain 2A (accession no 1YVB), falcipain 3 
(accession no 3BPM), and falcilysin (accession no 3S5M) 
were retrieved from RCSB Protein Data Bank. Homol-
ogy model of falcipain 2B was constructed using SWISS-
MODEL with falcipain 2A (accession no 1YVB) as a 
template, and the model was subsequently refined using 
AMBER03 force field in GROMACS and checked for 
Ramachandran outlier by RAMPAGE [25, 26]. Structural 
models were visualized by PyMOL.
Results
Evolution of Plasmodium Hb processing genes
Members of two Plasmodium protease families, falcipain 
and plasmepsin, have been functionally characterized as 
being Hb-specific [6]. Falcipain 2A, falcipain 2B, plas-
mepsin II, plasmepsin III, plasmepsin IV, and falcilysin 
are associated with the HDP complex (Fig.  1) [11], but 
both protease families also have members that function 
in pathways not related to Hb processing, and some are 
not expressed during the intra-erythrocytic stages [27].
Plasmepsin family
The phylogenetic tree of plasmepsin family reveals 
an expansion of food vacuole-specific Hb-targeting 
enzymes, namely, plasmepsin I–IV (Fig.  2). This clade 
contains a cluster of four food vacuole plasmepsins in P. 
falciparum and P. reichenowi while other Plasmodium 
spp., i.e., P. vivax, P. knowlesi, P. berghei, and P. yoelii, 
have one plasmepsin member in the clade (Fig.  2). The 
remaining members of the plasmepsin family, plasmepsin 
V-X, from every Plasmodium sp. can be grouped with 
homologues from other species of Apicomplexa with one 
member from each species (Fig. 2).
Falcipain family
Expansion of Hb-specific proteases in this family is less 
distinct. Even though Plasmodium falcipains are clus-
tered together, Hb-specific falcipains 2 and 3 are sepa-
rated from invasion-specific falcipain 1 (Fig.  3 and 
Additional file 3: Figure S1) [28, 29]. Plasmodium berghei 
and P. yoelii have two falcipain homologues dichotomi-
cally grouped with falcipains 1 and 2 (Fig. 3). Plasmodium 
falciparum and its close relative, P. reichenowi, have three 
members in the Hb-specific group, namely, falcipains 2A, 
2B and 3 (Fig. 3). The chromosomal region where falci-
pains 2A, 2B and 3 are located is designated a food-vac-
uole falcipain (fvf) locus due to their localization within 
the parasite (Fig.  4). In P. falciparum, the fvf locus is 
located on chromosome 11, with falcipain 2 and falcipain 
3 flanked by two conserved genes, histone methyltrans-
ferase Set 7 and one of the AP2 transcription factors. 
Every Plasmodium sp. with available genomic sequence 
shares a similar syntenic pattern with different numbers 
of falcipain genes at the fvf locus (Fig. 4).
Plasmodium falciparum has two copies of falcipain 
2, falcipain 2A and falcipain 2B that are almost identi-
cal (93.4  % identity at the amino acid sequence level) 
(Fig. 4). The presence of highly similar falcipain 2A and 
falcipain 2B genes at the same locus can result in gene 
conversion and promotion of genetic exchanges between 
the two repertoires, which might be a strong evolution-
ary driver for improving gene diversity [30] (Additional 
file 3: Figure S8). Plasmodium vivax and P. knowlesi also 
have three falcipain genes at their respective fvf locus, 
but the degree of similarity between the two species is 
approximately 70  %. There is only one falcipain gene at 
the fvf locus of P. berghei and P. yoelii, but the gene is still 
flanked by the conserved histone methyltransferase Set 7 
and one of the AP2 transcription factor genes.
Phylogenetic analysis established that members of the 
falcipain family exist as a common ancestor of Plasmo-
dium and independently undergo expansion. There was a 
diversification between falcipains specific to Hb digestion 
(falcipains 2 and 3 at the fvf locus) and falcipain 1 prior 
to malarial speciation (Fig.  3). Every Plasmodium sp. 
has a single falcipain 1 gene, and in the primate malaria 
parasite branch (P. falciparum, P. reichenowi, P. vivax, 
P. knowlesi), Hb-specific falcipain genes have expanded 
into three copies. Plasmodium vivax/P. knowlesi branch 
is clustered together with three matching pairs between 
the two species, suggesting that the expansion into three 
genes occurred prior to their speciation. Diversification 
into falcipain 2 and falcipain 3 in the P. falciparum/P. 
reichenowi branch is likely to be an independent event 
from that of P. vivax/P. knowlesi branch based on the 
phylogenetic tree structure (Fig. 3) [29].
It is worth noting that Theileria parva and Theileria 
annulata, members of the Apicomplexan species, have a 
large expansion of their falcipain family with ten putative 
members in their respective family prior to speciation 
(Additional file 3: Figure S1). The expansion might have 
facilitated their growth in both white and red blood cells. 
Nevertheless, the expansion into ten genes is not a neces-
sity for parasitism in red blood cells since Plasmodium 
and Babesia spp. have only three to four falcipain genes.
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Fig. 2 Haemoglobin-specific plasmepsin expansion in Plasmodium falciparum. a ML phylogenetic tree of plasmepsin. ML support value above 
75 % based on 100 replicates bootstrap is shown on the branch except plasmepsin I-IV clade. Plasmodium species are grouped with the homo-
logues from other members of Apicomplexa with one gene from each species. The tree shows separation of P. falciparum food vacuole plasmepsins 
(pink area) from plasmepsins localized in other cellular compartments or with different functions (light blue area). Sequences shown here were given 
code name according to their phylogenetic association with P. falciparum plasmepsin (see Additional file 1). Red branch: Pf P. falciparum, Pr P. reiche-
nowi, Pv P. vivax, Pk P. knowlesi, Pb P. berghei, Py P. yoelii, Yellow branch: Bb B. bovis, Bm B. microti, Orange branch: Tp T. parva, Ta T. annulata, Green branch: 
Et E. tenella, Blue branch: Tg T. gondii. b ML phylogenetic tree specific to Plasmodium plasmepsins shows the expansion of food vacuole plasmepsins 
in the P. falciparum/P. reichenowi lineage (red branch). P. vivax/P. knowlesi (blue branch) and P. berghei/P. yoelii (green branch) have only one plasmepsin 
gene in this clade. ML support value above 75 % based on 100 replicates bootstrap is shown on the branch. Star indicates that the node has <75 % 
bootstrap support based on 1000 replicates for NJ tree
Page 6 of 14Ponsuwanna et al. Malar J  (2016) 15:51 
Falcilysin family
Falcilysin is a member of metalloprotease family and 
is localized at the apicoplast and food vacuole [31, 32]. 
Peptides corresponded to P. falciparum falcilysin were 
identified by mass spectrometry during HDP complex 
purification [11]. A homologue of falcilysin is found in 
every Plasmodium sp., and the phylogenetic tree dem-
onstrates conventional species evolution in malaria 
parasites (Additional file 3: Figure S2) [33]. Plasmodium 
falcilysins are highly conserved with more than 70  % 
amino acid sequence similarity among Plasmodium spe-
cies. Both Theileria parva and Theileria annulata have 
two copies of falcilysin, and phylogenetic tree structure 
indicates that falcilysin duplication occurred before Thei-
leria speciation (Additional file 3: Figure S2).
HDP family
HDP is localized in malaria parasite food vacuole where 
it detoxifies haem released from digested Hb by facilitat-
ing the crystallization of haem into haemozoin [12]. HDP 
phylogenetic tree structure is similar to that of falcily-
sin (Additional file 3: Figure S3). Plasmodium HDPs are 
highly conserved and are essential for P. falciparum and 
P. berghei intra-erythrocytic development [10]. Blood 
parasites that do not produce haemozoin, such as Babe-
sia and Theileria, have only one copy of P. falciparum 
HDP homologue, suggesting that HDP in these two spe-
cies may have another function or that a different form of 
haemozoin exists.
Selective pressure on Hb processing genes
In order to understand the effects of selective pressure 
of drugs, such as artemisinin and chloroquine, the ratio 
between single nucleotide polymorphism (SNPs) causing 
non-synonymous mutations and synonymous mutations 
(N/S ratio) and the positions of mutated residues in the 
three-dimensional structures were determined [34, 35]. 
Bias towards non-synonymous mutations means that the 
gene of interest is under pressure to diversify, probably 
due to drug selective pressure. In addition, functional 
significance of these mutations could be reflected in their 
locations either at functional motif or as a cluster.
N/S ratios were analysed in samples collected from 
different parts of the world and those specific to South-
east Asia, a hot spot of anti-malarial resistance. As 
high-throughput sequencing data for falcipain 2A and 
2B are limited by their sequence similarity, nested-PCR 
falcipain 2A and 2B amplicons were sequenced from 
Fig. 3 ML phylogenetic tree of Plasmodium falcipains. Plasmodium falcipains form two separated clades of Hb-specific falcipains (pink area) 
and invasion-specific falcipains (light blue area). The expansion of Hb-specific falcipains in human/primate Plasmodium occurred separately in P. 
falciparum/P. reichenowi lineage (red branch line) and P. vivax/P. knowlesi lineage (blue branch line). Falcipain expansion is not evident in P. yoelii/P. 
berghei lineage (green branch line). Numeric value shown on the branch indicates ML support value above 75 % based on 100 replicates bootstrap. 
NJ phylogenetic tree was also inferred. Bootstrap value for NJ tree was calculated from 1000 tree replicates. Both NJ and ML trees have comparable 
tree topology (data not shown) with high bootstrap support. Only ML tree is shown here. Star indicates that the node has <75 % NJ bootstrap sup-
port. Sequences shown here were given code name (see Additional file 1)
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artemisinin-resistant ANL2 and ANL4 and artemisinin-
sensitive ANL1 and ANL3 strains obtained from the 
same area [36]. Mutations data are listed in Additional 
file 4 and Additional file 5.
Analysis of N/S ratio revealed that HDP and the major-
ity of non-Hb targeting plasmepsin genes are not under 
positive selection (Fig.  5). Worldwide, falcipain 2A and 
falcipain 2B significantly have more SNPs with non-syn-
onymous than those with synonymous mutations. When 
the analysis is limited to Southeast Asia, the N/S ratio for 
falcilysin, falcipain 2B, plasmepsin I, and plasmepsin III 
are elevated, but, surprising, not that of plasmepsin IV.
Plasmepsin
Plasmepsin I-IV have the pepsin-like structure. The 
overall structure, as in other eukaryotic aspartic pro-
teases, can be divided into N-terminal and C-terminal 
domains, each composed of highly twisted β-sheets, 
small α-helices and an intra-domain disulfide bond, with 
the two domains connected by a six-stranded β-sheet 
(Fig.  6a) [37]. The N-terminal domain contains a ‘flap’ 
β-hairpin that covers the active site in the presence of 
substrate. The active sites of plasmepsin I, II and IV con-
sist of the conventional aspartic protease catalytic dyad 
that contains two aspartate residues, one from the N- and 
the other from C-terminal domain. Plasmepsin III (histo-
aspartic protease—HAP) catalytic dyad is composed of 
one histidine and one aspartate residue [38].
The three mutations of plasmepsin I found in Southeast 
Asia are located in close proximity on the enzyme sur-
face (Additional file 3: Figure S4). N148I and L180H are 
exclusive to Southeast Asia and I213V is found in South-
east Asia and South Asia. Mutation F112L is also specific 
to Southeast Asia (allele frequency =  0.2  %) and South 
Asia (allele frequency = 3.9 %). Its location is in the pro-
domain region, which was not included in the structure.
Plasmepsin II mutations (V133A, Y141C, E145D, 
T154I, D286N, T289I), found in Asia and Africa except 
for Southeast Asia-specific C141 variant, also form a 
cluster on the negatively charged surface (Fig. 6a). N286 
variant is found more often in Southeast Asia (allele fre-
quency = 1.4 %) than in Africa (allele frequency < 0.1 %). 
Mutations L321F and A323T/V, found in Asia and Africa, 
are located on the same side of a β-strand in the interior 
hydrophobic milieu of the enzyme (Additional file 3: Fig-
ure S5). The Southeast Asia-specific L411V mutation is 
located also within the enzyme interior and close to the 
substrate-binding cleft (Additional file  3: Figure S5). 
Fig. 4 Food-vacuole falcipain loci in Plasmodium. Haemoglobin-specific falcipains (shown in red and pink) are located in close proximity as a 
falcipain locus. The genes surrounding the falcipain locus are conserved among Plasmodium species. Falcipain 2A of P. reichenowi is not shown here. 
P. falciparum falcipain 2A and falcipain 2B (yellow border) are almost identical to one another. Red dashed lines indicate falcipain 2B and falcipain 3 
homologues in P. reichenowi. The scaled line length is approximately 10 kb
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Mutations N271S and Y302H, located on the surface, are 
exclusive to Southeast Asia (Additional file 3: Figure S5).
Plasmepsin III mutations N411K and G233R are 
located near the substrate-binding cleft (Fig.  6b), with 
K411 variant found only in Southeast Asia (allele fre-
quency = 0.1 %) and R233 variant throughout Asia (allele 
frequency >20 %). Plasmepsin III has a surface negative-
charge patch similar to that of plasmepsin II but at a dif-
ferent location and contains mutation E173V that is not 
specific to Southeast Asia (Fig. 6b).
Plasmepsin IV mutation P397S, located near the sub-
strate-binding pocket, is specific to Southeast Asia (allele 
frequency = 0.5 %) and is in the same binding pocket as 
plasmepsin III K411 variant (Additional file 3: Figure S6). 
Mutation N268K is equivalent to plasmepsin II N271S, 
but is not unique to Southeast Asia (Additional file  3: 
Figure S6). Of the three mutations, N272I, R353T and 
N268K, N272I variant is specific to Southeast Asia (allele 
frequency  =  0.1  %) and R353T variant is global (allele 
frequency = 30.8 %).
Falcipain
The structures of falcipain 2A and falcipain 3 catalytic 
domain are similar to other papain-like cysteine pro-
teases (Fig. 7) [39, 40], being composed of a triad C285, 
H417 and N447 in falcipain 2A and C293, H425 and 
N455 in falcipain 3. In general, falcipain is structurally 
composed of five α-helices and nine β-strands, divided 
into two domains, L (composed mainly of α-helices) and 
R (containing one β-sheet and two small α-helices), which 
are arranged sequentially in primary sequence (Fig.  7) 
[39, 40]. The active site of falcipain is located between 
the L and R domains. Falcipains contain a unique ‘nose’ 
domain which is a 16-residue N-terminal extension 
bridging the L and R domains, and an ‘arm’ domain con-
sisting of β6 and β7 strands from the R domain. The arm 
region is a putative haemoglobin binding domain (Fig. 7). 
Deletion of the 10 amino acid residues located at the tip 
reduced overall haemoglobinase activity without any del-
eterious effect on protease [41]. So far, no mutation was 
found at the arm domain.
Falcipain 2A mutation A400P is located in α5 helix 
(thereby causing a kink) that is close to the substrate-
binding cleft and is likely to come from falcipain 2B 
(Fig. 7). This mutation is found in Asia and Africa (global 
allele frequency  =  0.3  %). Falcipain 2B also has the 
matching mutation of P398A, again as the result of gene 
conversion. Falcipain 2B A398 variant is found world-
wide (allele frequency =  11  %) but with a lower preva-
lence (6.4 %) in Southeast Asia.
Fig. 5 Ratio of non-synonymous and synonymous mutation (N/S ratio) of HDP complex enzymes. Reported mutations from MalariaGen Database 
were used to calculate N/S ratio. For falcipain 2A and falcipain 2B, mutations found from manual sequencing of ANL1-ANL4 clones were included in 
the dataset. Ratio above 1 (marked by dashed line) might imply positive selection
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Fig. 6 Non-synonymous mutations in plasmepsin II and plasmepsin III. a Structural composition of plasmepsin II is shown as a ribbon diagram (top 
left panel). The N-terminal domain is shown in green and the C-terminal domain is shown in blue. The inter-domain β-sheet is located at the bottom 
of the structure, containing three β-strands from N-terminal and C-terminal domains. The orange β-hairpin forms the flap covering the active site. 
The catalytic dyad, Asp157 from the N-terminal domain and Asp337 from the C-terminal domain, are coloured in yellow. Plasmepsin II mutations 
are shown on the surface (bottom left panel) with colour intensity in pink shade representing allele frequency in Southeast Asia. Six mutations are 
clustered on the surface of plasmepsin II; D286N (1.4 %), Y141C and T154I (0.1 %), V133A, E145D and T289I (<0.1 %). Y141C was found exclusively 
in Southeast Asia. V133A, E145D, D286N, and T289I are from Southeast Asia and Africa. T154I was found in South Asia, Southeast Asia and Africa. 
Electrostatic potential surface of plasmepsin II reveals the large negative-charged patch (bottom right panel). The surface area contributed by D286 
is marked by dashed circle. b Electrostatic potential surface of plasmepsin III (HAP) reveals large negative-charged patch (left panel). The surface 
area contributed by E173 is identified by dashed circle. Mutation E173V could be found with allele frequency <0.1 % in Southeast Asia and 0.1 % in 
West Africa. Mutation N411K (right panel, pink surface), which is a residue lining the substrate-binding cleft, is present only in Southeast Asia with the 
allele frequency of 0.1 %. The G233R mutation (right panel, purple surface) on the surface near substrate-binding cleft has allele frequency >20 % in 
Southeast Asia, South Asia and Papua New Guinea. Arginine at the position 233 was modelled and shown as purple stick. Pepstatin A is shown as 
black stick. Plasmepsin II structure was taken from PDB ID: 1XDH. HAP structure was taken from PDB ID: 3FNT
Page 10 of 14Ponsuwanna et al. Malar J  (2016) 15:51 
Falcipain 2A mutation M245I, equivalent to muta-
tion I243M in falcipain 2B, is more prevalent in Africa 
(allele frequency  =  2.1  %) than in Southeast Asia 
(allele frequency  =  0.1  %), but conversely, falcipain 
2B M243 variant is more prevalent in Southeast Asia 
(allele frequency  =  2.9  %) than in Africa (allele fre-
quency = 0.6 %). These mutations are located in α1 helix 
of the ‘nose’ domain (Fig. 7).
Falcipain 2A mutation Q414E, found in P. falciparum 
ANL1 and ANL2 strains, is located in the negative-charge 
Fig. 7 Mutations in falcipain 2A and falcipain 2B. Key domains of falcipain are shown in the top left panel. Arm and nose domains are unique in 
Plasmodium falcipain. Cyan stick indicates conversion mutation. Yellow stick indicates non-conversion mutation that is similar to falcipain 2A varia-
tion in W2 strain. Red stick indicates non-conversion mutation that does not originate from W2. Red stars label the location of active site. Electrostatic 
potential surface of falcipain 2A and falcipain 2B is shown (bottom panel). Surface potential contribution from Q414 and E412 is circled in yellow dot-
ted line. Green dashed lines mark the active site cleft. Falcipain 2A structure, which was taken from PDB ID: 1YVB is originally from P. falciparum strain 
W2. Falcipain 2B is a homology model using 1YVB as a template
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patch that extends from the Hb-binding ‘arm’ domain to 
the surface area near the active site cleft (Fig. 7). In com-
parison to 3D7, falcipain 2A mutations K255R, N257E, 
T343P and D345G were found in ANL strains (Addi-
tional file 4), and are identical to those in the W2 strain 
that has a shared origin from Southeast Asia. R255 and 
E257 substitutions are located close to each other at the 
‘nose’ domain, while P343 and G345 substitutions are 
located in close proximity in a loop connecting α4 helix 
and β1 sheet at the opposite side of the ‘arm’ domain 
(Fig. 7).
Falcipain 2B mutations I243M and D246E are present 
in the ‘nose’ domain, with the former located in α1 helix. 
Mutation A297V, found in ANL4 strain, is located in α2 
helix. I391V mutation, found in ANL1, is located in the 
interior hydrophobic milieu of the enzyme and has a 
global allele frequency of 10.5 %.
Falcipain 3 mutations A264V, N371K, R411K, and 
N468Y were found in Southeast Asia but they are also 
present in Africa. K371 substitution is located at the neg-
ative-charge surface of L domain; K411 and Y468 lie close 
to the ‘arm’ domain; and V264 is located in the ‘nose’ 
domain (Additional file 3: Figure S7).
Falcilysin
Falcilysin is a zinc-metalloprotease structurally divided 
into two similar N-terminal and C-terminal domains, 
each composed of two αβ rolls, with the catalytic site 
situated in the central cavity of the first αβ roll of the 
N-terminal domain (Fig.  8). The zinc-binding motif is 
composed of residues HXXEHX109E and the zinc atom is 
coordinated to H129, H133 and E243 and a water mol-
ecule. It has different substrate specificity depending on 
pH [42].
Ten mutations (T752S, Q812H, D841Y, I888N, E893D, 
K910M, R918C, V972L, T976A/I, S986N/R) found in P. 
falciparum worldwide are clustered on the same outer 
surface of the C-terminal domain (Fig. 8a). M910 (allele 
frequency  =  1  %) and N986 (allele frequency  =  0.1  %) 
variants are Southeast Asia-specific. In addition, muta-
tion L453M, located on the inner surface of the enzyme 
substrate cavity, is specific to Southeast Asia (allele fre-
quency = 0.1 %) (Fig. 8b).
HDP
At present, the structural information on HDP is not 
available. A biochemical study showed the importance 
of key conserved histidine residues (Histidine 122, 172, 
175, and 197 in P. falciparum) in haemozoin forma-
tion [43]. Four SNPs are found in Southeast Asia at the 
gene encoding HDP, but only charge-reversion E112K 
is specific to Southeast Asia (allele frequency =  0.1  %). 
The data from MalariaGEN suggested that C41F (allele 
frequency  =  0.2  %) was found only in Southeast Asia, 
but this mutation was previously reported in the HB3 
strain originated from South America [44]. The other two 
mutations, V164I and I185T, can be found in Southeast 
Asia and Africa.
Discussion
Changes in gene dosage by gene duplication play an 
important role in the survival of malaria parasites under 
drug-induced stress. One of the original observations 
was the amplification of P. falciparum mdr1, linked to 
resistance to mefloquine [45]. Amplification of GTP 
cyclohydrolase I gene, encoding the upstream rate-lim-
iting enzyme in the malaria parasite folate pathway, not 
only results in antifolate resistance, but also drives the 
evolution of drug resistance of other genes in the folate 
pathway [46, 47]. Nevertheless, too many copies of a par-
ticular gene could be deleterious to an organism. Mutu-
ally exclusive expression of multigene families is often 
adopted in P. falciparum to select a sub-set of genes to be 
expressed at a particular time or stage of development in 
order to gain a selective advantage [48].
Analysis of Hb processing genes in Plasmodium and 
Apicomplexan spp. has revealed expansion of protease 
genes (encoding plasmepsin, falcipain and falcilysin) 
specific to malaria parasites. Hb-specific plasmepsin is 
encoded by a single gene in every Plasmodium sp. except 
for P. falciparum/P. rechenowi clade where there are four 
plasmepsin genes, whereas the remaining members of the 
family (plasmepsin V-X) that do not degrade Hb are con-
served in other Plasmodium and Apicomplexan spp. The 
expansion of Hb-specific plasmepsin genes indicates a 
strong selective advantage in maintaining large amounts 
of such plasmepsin. However, loss of plasmepsin I–IV by 
genetic ablation does not create a lethal phenotype [49]. 
In addition to the effect of gene dosage on protein expres-
sion level, gene expansion promotes genetic diversity by 
allowing tolerance to deleterious mutations present in 
one or more of the genes. Plasmepsin gene expansion 
probably is not due to direct selective pressure of anti-
malarial interventions as the phenomenon also is found 
in P. reichenowi. Plasmepsin gene expansion itself is not 
needed for survival in the human host as P. vivax only has 
one Hb-specific plasmepsin gene copy. It is possible that 
increased plasmepsin gene expansion promotes Hb con-
sumption in red blood cells allowing effective propaga-
tion in Hb-rich mature red blood cells. This notion needs 
to be tested in other Plasmodium spp.
Furthermore, the presence of closely similar genes, 
e.g., falcipain 2A and 2B, allows genetic variation by 
means of gene conversion. Falcipain gene duplications 
at the fvf locus are found in both P. falciparum/P. reiche-
nowi and P. vivax/P. knowlesi clades and have occurred 
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independently based on the constructed phylogenetic 
tree and close homology between falcipain 2A and 2B.
Two components of the haem processing genes, HDP 
and falcilysin, have only one copy per genome. It is not 
unexpected that their deletions are lethal to malaria par-
asites [10]. The degree of diversification for HDP is low 
with an N/S ratio of 1 (Fig. 5). Falcilysin does not have a 
high N/S ratio at the global scale, but this ratio is higher 
among P. falciparum isolates in Southeast Asia (Fig. 5).
The majority of non-synonymous mutations in P. fal-
ciparum falcipain 2A, falcipain 2B and falcipain 3 are 
located more in the prodomain than in core enzyme, 
contrary to those observed for plasmepsins (Additional 
file 5). This preference may indicate a strong requirement 
Fig. 8 Falcilysin mutations found in Southeast Asia. a Structure of falcilysin is shown as ribbon diagram (left panel). The N-terminal and C-terminal 
domains are coloured in dark green and blue, respectively. Clusters of ten Southeast Asia mutations on the outer surface of the C-terminal domain 
of falcilysin are shown in pink with shade representing allele frequency (right panel). K910M and S986N are Southeast Asia-exclusive mutations (allele 
frequencies of 1 and 0.1 %, respectively). S986R could be found predominantly in South Asia (1.4 %), Southeast Asia (0.1 %) and Africa (<0.1 %). 
T752S and E893D are more common in Southeast Asia (allele frequency of 2.2 and 0.3 %, respectively) but could also be found in Africa (allele fre-
quency 0.1 and <0.1 %, respectively). Q812H, D841Y, I888N, R918C, V972L, and T976A/I are found at low frequencies (<0.1 %) in Southeast Asia and 
Africa. b Cross-section of falcilysin showing central cavity. The locations of catalytic zinc atom (cyan star) and Southeast Asia-specific L453M (orange 
star) inside the central cavity are indicated. It is the only mutation found in Southeast Asia that is located inside the central cavity. This allele has 
allele frequency of 0.1 %. Falcilysin active site is shown in the inset. L453M is shown as pink stick. Zinc is coordinated by His129, His133 and Glu243. 
Falcilysin structures were obtained from PDB ID: 3S5K and 3S5I
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for intact enzymes over protein regulation mediated by 
the prodomain sequence. Even though no direct protease 
inhibitor has been adopted for malaria treatment, com-
pounds in both 4-aminoquinoline and artemisinin fami-
lies are known to perturb haemoglobin degradation and 
haemozoin formation [11]. Their activities could impose 
selective pressure on haemoglobin-specific proteases 
since genetic alterations at the Hb processing genes were 
experimentally linked to reduced drug sensitivity [10, 13].
Selective pressure on Hb processing genes can be 
observed by analysing the N/S ratio of existing SNPs. N/S 
ratio analysis revealed that HDP and most non Hb-target-
ing plasmepsin genes are not under positive selection. On a 
global scale, falcipain 2A and falcipain 2B significantly have 
more SNPs with non-synonymous mutations than those 
with synonymous mutations. When the analysis is limited 
to parasites from Southeast Asia, N/S ratio for falcilysin, 
plasmepsin I and plasmepsin III are elevated significantly. 
Another important factor is gene conversion between falci-
pain 2A and falcipain 2B. Sequence analysis of a few strains 
showed extensive exchanges between the two genes. This 
issue has been largely overlooked because these two genes 
are considered a ‘blind spot’ in whole genome sequencing. 
Analysis of these genes by an alternative approach, such 
as PCR-based sequencing as conducted in this study, may 
reveal correlations between falcipain mutations and drug 
resistance, especially given the fact that gene conversion 
increases genetic diversity [30].
Conclusion
This study demonstrates that Plasmodium Hb processing 
genes are currently under-appreciated despite the degree of 
evolutionary pressure to expand and diversify. This is due 
largely in part to the lack of lethal intra-erythrocytic-stage 
phenotypes as ex  vivo gene knock-out experiments were 
performed in rich media culture, which may have prevented 
the generation of such phenotypes. Adaptation of more 
stringent growth conditions could reveal hidden phenotypes 
of intra-erythrocytic-stage parasites (Bunditvorapoom et al., 
unpublished data). Systemic analysis of malaria parasite Hb 
processing genes will be important in dissecting their roles 
in developing drug resistance and in pathogenesis.
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